By Therapeutic Area

Infectious Disease (Fungal HAI) Market Analysis

Cross-industry research covering Infectious Disease (Fungal HAI) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Infectious Disease (Fungal HAI)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Azole-resistant Aspergillus fumigatus (nct:NCT06532227) and rising Candida auris prevalence are expanding antifungal formulary requirements beyond standard fluconazole prophylaxis, forcing hospital pharmacies toward echinocandins and novel polyenes at significantly higher WAC. The global triazole antifungal HAI pool is estimated at USD 2.1B (Claritas model).

14%

Market Share

7.2%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments